ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Pharmacy Professor, Students Begin Grant-Supported Research to Engineer Designer Drug Molecules – Ferris State Torch

Ferris State TorchPharmacy Professor, Students Begin Grant-Supported Research to Engineer Designer Drug MoleculesFerris State TorchFurthermore, employing synthetic biology to redesign these natural systems also involves metabolic engineering, which con… Continue reading

2018-01-11 Michael Zand NEWS

Practicality of CAR T Therapy – OncLive

Continue reading

2018-01-11 Michael Zand NEWS

Kite Earns Patent for Method to Increase Efficacy of CAR-T – Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology NewsKite Earns Patent for Method to Increase Efficacy of CAR-TGenetic Engineering & Biotechnology NewsThe patent could potentially cause trouble for other companies that are also working to develop cancer treatments … Continue reading

2018-01-11 Michael Zand NEWS

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer – OncLive


OncLive

Practicality of CAR T Therapy
OncLive
Stephen J. Schuster, MD: I think, currently, the products can be prepared within 17 to 22 days, depending on which CAR you’re talking about. And that seems like a relatively short period of time but in a very sick patient who has a rapidly progressing …

Continue reading

2018-01-11 Michael Zand NEWS

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer – OncLive


OncLive

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer
OncLive
Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) testing may improve classifications of endometrial cancer and lead to personalized treatment options, according to Martee L. Hensley, MD. If patients’ tumors test positive …

Continue reading

2018-01-11 Michael Zand NEWS

Investigational Gene Therapy Produced 2 Year Immunity Against HIV – Specialty Pharmacy Times

Investigational Gene Therapy Produced 2 Year Immunity Against HIVSpecialty Pharmacy TimesIn 2017, the FDA approved the very first gene therapy, tisagenlecleucel (Kymriah) for refractory B-cell precursor acute lymphoblastic leukemia, and subsequently ap… Continue reading

2018-01-11 Michael Zand NEWS

Immunotherapy in Second-Line Advanced Bladder Cancer – OncLive

OncLiveImmunotherapy in Second-Line Advanced Bladder CancerOncLiveDaniel J. George, MD: 2017 into 2018 is going to be a transition period in bladder cancer, particularly for patients who are in the second-line setting. Still today, many of our patients… Continue reading

2018-01-11 Michael Zand NEWS

Immunotherapy in Second-Line Advanced Bladder Cancer – OncLive

OncLiveImmunotherapy in Second-Line Advanced Bladder CancerOncLiveDaniel J. George, MD: 2017 into 2018 is going to be a transition period in bladder cancer, particularly for patients who are in the second-line setting. Still today, many of our patients… Continue reading

2018-01-11 Michael Zand NEWS
  • 1
  • …
  • 675
  • 676
  • 677
  • 678
  • 679
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

OncLive

Expert Highlights Genetic Testing, Immunotherapy in Endometrial Cancer
OncLive
Mismatch repair deficiency (dMMR) and microsatellite instability-high (MSI-H) testing may improve classifications of endometrial cancer and lead to personalized treatment options, according to Martee L. Hensley, MD. If patients’ tumors test positive …